|
Adult Treatment Panel (ATP) III Analysis
|
ATP III Calculator
|
|
Note: The latest guidelines (ATP-IV - Pooled cohort equations).
This program will calculate the Framingham 10-year
risk percentage as well as provide treatment
guidelines based on the latest clinical data. |
|
Age:
Gender: Smoking status: |
Systolic Blood Pressure (SBP):
mmHg
|
Total cholesterol:mg/dl Triglyceride level:
|
|
HDL: mg/dl LDL:
|
|
Taking medication for blood pressure?
|
Are
any of the following present ?
(review factors under 1, and 2)
1) Clinical coronary heart disease (CHD): Includes history of
:
a) myocardial infarction,
b) unstable angina or stable angina,
c) coronary artery procedures (angioplasty or bypass surgery), or
d) evidence of clinically significant myocardial ischemia.
2) CHD Risk equivalents: includes clinical manifestations of noncoronary forms of atherosclerotic disease:
a) peripheral arterial disease,
b) abdominal aortic aneurysm,
c) carotid artery disease (transient ischemic attacks or stroke of carotid origin or
>50%
obstruction of a carotid artery),
d) diabetes ,
e) ≥ 2 risk factors with 10-year
risk for hard CHD >20%. |
How
many of the following risk factors are present
if any?
(Note: if HDL ≥
60, subtract one from the total count).
1) Cigarette smoking
2) Hypertension (BP
≥ 140/90 mmHg or on antihypertensive medication)
3)
Low HDL cholesterol (<40 mg/dL)
4) Family history of premature CHD
(CHD in male first degree relative <55 years;
CHD in female first degree relative <65 years).
5)
Age (men ≥45 years; women
≥55 years) |
Metabolic Syndrome - Are at least 3 of the following
present after 3 months of therapeutic lifestyle changes?
1) Abdominal obesity (Waist circumference)
Men: >102 cm >40 in)
Women: >88 cm (>35 in)
2.) Triglycerides ≥
150 mg/dL |
3.) HDL cholesterol
Men: <40 mg/dL
Women: <50 mg/dL
4.) Blood pressure: ≥130/≥
85 mmHg
5.) Fasting glucose: ≥110
mg/dL |
|
|
|
References:
|
1) Grundy SM, Cleeman JI, Bairey Merz CN, et al, for the Coordinating
Committee of the National Cholesterol Education Program. Implications
of recent clinical trials for the National Cholesterol Education
Program Adult Treatment Panel III guidelines. Circulation.
2004;110:227-239.
2) Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults. Executive summary of the third report of the
National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497. |
